The clinicopathological features among the two subgroups showed no difference, except a little among the metastasis status of tumor patients with high CD146 expression who met more tumor metastasis whether at or after diagnosis (p = 0.042, Table 3). The gene discussed is MCAM; the disease is neoplasm.